Interval training and mindfulness breathing for postmenopausal women
High-intensity Interval Training and Mindfulness Breathing Induce Hormonal and Metabolic Effects and Alter Tumor Marker Levels in Obese Postmenopausal Women: A Randomized Controlled Trial
This study is testing if a combination of high-intensity interval training and mindfulness breathing can improve health markers in postmenopausal women.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 55 Years to 65 Years |
| Sex | Female |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT04471506 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effects of interval aerobic training and mindfulness breathing on hormonal, metabolic, and tumor markers in postmenopausal women. Participants will engage in a high-intensity interval training program three times a week for three months, combined with mindfulness breathing exercises. The study will monitor changes in insulin resistance and other related health markers, with a focus on improving overall health outcomes for this demographic. The exercise sessions will be supervised initially to ensure proper technique and safety.
Who should consider this trial
Good fit: Ideal candidates are postmenopausal women aged 55-65 with a BMI between 35 and 39.9 kg/m2.
Not a fit: Patients with active chronic illnesses, cognitive impairments, or those currently on weight-reduction interventions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve metabolic health and reduce cancer risk in postmenopausal women.
How similar studies have performed: While similar approaches have been explored, this specific combination of interval training and mindfulness breathing in postmenopausal women is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Sixty Postmenopausal women (55-65 y) * Body mass index (BMI) ranged from 35 to 39.9 kg/m2 * Postmenopausal more than 2 years Exclusion Criteria: * • women receiving weight-reduction interventions * taking lipid lowering drugs * regular medications(e.g., β-blockers, α-blockers, digoxin, diuretics, aspirin, nitrates, Presently using sex hormones) * having active chronic illness (e.g., rheumatoid arthritis, hyperthyroidism, and inflammatory bowel disease) and diabetes mellitus or other (unstable) endocrine-related diseases * cognitive impairment that will make it difficult to partake in the study * presence of malignant disease * blood donation within the last 30 days * Participation as a subject in any type of study or research during the prior 90 days * smoking
Where this trial is running
Cairo
- Physical Therapy — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: marwa m elsayed, phd — lecturer at physical therapy faculty cairo university
- Study coordinator: marwa m elsayed, phd
- Email: marwadd999@gmail.com
- Phone: 01156033818
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.